| Dr Viet Ngoc Bui, MD | |
|
2020 Fleischmann Rd, Tallahassee, FL 32308-4599 | |
| (850) 878-6161 | |
| Not Available |
| Full Name | Dr Viet Ngoc Bui |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 22 Years |
| Location | 2020 Fleischmann Rd, Tallahassee, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730136904 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | ME104798 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eye Associates Of Tallahassee, P.a. | 7315900370 | 10 |
News Archive
Levels of a widely used class of industrial chemicals linked with cancer and other health problems-polyfluoroalkyl and perfluoroalkyl substances (PFASs)-exceed federally recommended safety levels in public drinking water supplies for six million people in the U.S., according to a new study led by researchers from Harvard T.H. Chan School of Public Health and the Harvard John A. Paulson School of Engineering and Applied Sciences.
Multiple myeloma, a type of blood cancer in which malignant plasma cells are overproduced in the bone marrow, has led to an estimated 20,000 new diagnoses and 11,000 deaths in 2010. Patients with the disease, who have already failed previous treatments, may be considered for a currently enrolling Phase II study, examining a unique drug combination.
TargeGen, Inc. today announced that the Company has successfully completed a 59 patient, multicenter clinical trial of TG101348, an oral, potent, and highly selective inhibitor of JAK2 in patients with myelofibrosis.
Reverse Medical Corporation today announced CE Mark approval for European commercialization of their BARREL Vascular Reconstruction Device and the first European clinical case. The BARREL Vascular Reconstruction Device is intended for use with occlusive devices in the treatment of intracranial aneurysms.
› Verified 4 days ago
| Entity Name | Eye Associates Of Tallahassee, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750388203 PECOS PAC ID: 7315900370 Enrollment ID: O20041110000618 |
News Archive
Levels of a widely used class of industrial chemicals linked with cancer and other health problems-polyfluoroalkyl and perfluoroalkyl substances (PFASs)-exceed federally recommended safety levels in public drinking water supplies for six million people in the U.S., according to a new study led by researchers from Harvard T.H. Chan School of Public Health and the Harvard John A. Paulson School of Engineering and Applied Sciences.
Multiple myeloma, a type of blood cancer in which malignant plasma cells are overproduced in the bone marrow, has led to an estimated 20,000 new diagnoses and 11,000 deaths in 2010. Patients with the disease, who have already failed previous treatments, may be considered for a currently enrolling Phase II study, examining a unique drug combination.
TargeGen, Inc. today announced that the Company has successfully completed a 59 patient, multicenter clinical trial of TG101348, an oral, potent, and highly selective inhibitor of JAK2 in patients with myelofibrosis.
Reverse Medical Corporation today announced CE Mark approval for European commercialization of their BARREL Vascular Reconstruction Device and the first European clinical case. The BARREL Vascular Reconstruction Device is intended for use with occlusive devices in the treatment of intracranial aneurysms.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Viet Ngoc Bui, MD 2020 Fleischmann Rd, Tallahassee, FL 32308-4599 Ph: (850) 878-6161 | Dr Viet Ngoc Bui, MD 2020 Fleischmann Rd, Tallahassee, FL 32308-4599 Ph: (850) 878-6161 |
News Archive
Levels of a widely used class of industrial chemicals linked with cancer and other health problems-polyfluoroalkyl and perfluoroalkyl substances (PFASs)-exceed federally recommended safety levels in public drinking water supplies for six million people in the U.S., according to a new study led by researchers from Harvard T.H. Chan School of Public Health and the Harvard John A. Paulson School of Engineering and Applied Sciences.
Multiple myeloma, a type of blood cancer in which malignant plasma cells are overproduced in the bone marrow, has led to an estimated 20,000 new diagnoses and 11,000 deaths in 2010. Patients with the disease, who have already failed previous treatments, may be considered for a currently enrolling Phase II study, examining a unique drug combination.
TargeGen, Inc. today announced that the Company has successfully completed a 59 patient, multicenter clinical trial of TG101348, an oral, potent, and highly selective inhibitor of JAK2 in patients with myelofibrosis.
Reverse Medical Corporation today announced CE Mark approval for European commercialization of their BARREL Vascular Reconstruction Device and the first European clinical case. The BARREL Vascular Reconstruction Device is intended for use with occlusive devices in the treatment of intracranial aneurysms.
› Verified 4 days ago
Dr. Joel H Kramer, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1401 Centerville Rd, Suite 404, Tallahassee, FL 32308 Phone: 850-385-2095 Fax: 850-656-2255 | |
Dr. Robert L Steinmetz, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2439 Care Dr, Tallahassee, FL 32308 Phone: 850-942-6700 Fax: 850-942-5735 | |
Fang Sarah Ko, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2020 Fleischmann Rd, Tallahassee, FL 32308 Phone: 850-878-6161 Fax: 850-656-0200 | |
Dr. Richard Mark Palmer, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2535 Capital Medical Blvd, Tallahassee, FL 32308 Phone: 850-877-7337 Fax: 850-877-8675 | |
Dr. Charles K Newell, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2439 Care Dr, Tallahassee, FL 32308 Phone: 850-942-6700 Fax: 850-942-5735 | |
Dr. Nicholas Craig Farber, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2349 Care Drive, Tallahassee, FL 32308 Phone: 850-942-6700 | |
Dr. Deanna Macy Louie, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2020 Fleischmann Rd, Tallahassee, FL 32308 Phone: 850-878-6161 Fax: 850-626-0200 |